Table of Content

1. Methodology and Scope
1.1. Research Methodology
1.2. Research Objective and Scope of the Report
2. Definition and Overview
3. Executive Summary
3.1. Snippet by Process Type
3.2. Snippet by Service Type
3.3. Snippet by Application Type
3.4. Snippet by End User
3.5. Snippet by Region
4. Dynamics
4.1. Impacting Factors
4.1.1. Drivers
4.1.1.1. The Rising Prevalence of Chronic Diseases
4.1.1.2. The Increasing R&D Expenditure
4.1.2. Restraints
4.1.2.1. The High Cost of Drug Discovery Process
4.1.3. Opportunity
4.1.3.1. 3D-bioprinting to create advanced drug models
4.1.4. Impact Analysis
5. Industry Analysis
5.1. Porter’s 5 Forces Analysis
5.2. Supply Chain Analysis
5.3. Unmet Needs
5.4. Regulatory Analysis
6. COVID-19 Analysis
6.1. Analysis of COVID-19
6.1.1. Scenario Before COVID-19
6.1.2. Scenario During COVID-19
6.1.3. Scenario Post COVID-19
6.2. Pricing Dynamics Amid COVID-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During the Pandemic
6.5. Manufacturers’ Strategic Initiatives
6.6. Conclusion
7. Russia-Ukraine War Analysis
8. By Process Type
8.1. Introduction
8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process Type
8.1.2. Market Attractiveness Index, By Process Type
8.2. Profiling & Lead Optimization*
8.2.1. Introduction
8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Screening
8.4. Assay Development
8.5. Cell Engineering
8.6. Others
9. By Service Type
9.1. Introduction
9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
9.1.2. Market Attractiveness Index, By Service Type
9.2. Computational Chemistry*
9.2.1. Introduction
9.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
9.3. Medical Chemistry
9.4. ADME & DMPK
9.5. Biochemistry
9.6. Others
10. By Application
10.1. Introduction
10.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application
10.1.2. Market Attractiveness Index, By Application
10.2. Oncology*
10.2.1. Introduction
10.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
10.3. Neurology
10.4. Metabolic & Inflammatory Disease
10.5. Immuno-Oncology
10.6. Others
11. By End User
11.1. Introduction
11.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User
11.1.2. Market Attractiveness Index, By End User
11.2. Pharmaceutical & Biotechnology companies*
11.2.1. Introduction
11.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
11.3. Clinics
11.4. Academic Institutes
11.5. Others
12. By Region
12.1. Introduction
12.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
12.1.2. Market Attractiveness Index, By Region
12.2. North America
12.2.1. Introduction
12.2.2. Key Region-Specific Dynamics
12.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process Type
12.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
12.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application Type
12.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User Type
12.2.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.2.7.1. The U.S.
12.2.7.2. Canada
12.2.7.3. Mexico
12.3. Europe
12.3.1. Introduction
12.3.2. Key Region-Specific Dynamics
12.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process Type
12.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
12.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application Type
12.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User Type
12.3.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.3.7.1. Germany
12.3.7.2. The U.K.
12.3.7.3. France
12.3.7.4. Italy
12.3.7.5. Spain
12.3.7.6. Rest of Europe
12.4. South America
12.4.1. Introduction
12.4.2. Key Region-Specific Dynamics
12.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process Type
12.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
12.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application Type
12.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User Type
12.4.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.4.7.1. Brazil
12.4.7.2. Argentina
12.4.7.3. Rest of South America
12.5. Asia-Pacific
12.5.1. Introduction
12.5.2. Key Region-Specific Dynamics
12.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process Type
12.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
12.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application Type
12.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User Type
12.5.7. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
12.5.7.1. China
12.5.7.2. India
12.5.7.3. Japan
12.5.7.4. Australia
12.5.7.5. Rest of Asia-Pacific
12.6. Middle East and Africa
12.6.1. Introduction
12.6.2. Key Region-Specific Dynamics
12.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Process Type
12.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Service Type
12.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Application Type
12.6.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By End User Type
13. Competitive Landscape
13.1. Competitive Scenario
13.2. Product Benchmarking
13.3. Company Share Analysis
13.4. Key Developments and Strategies
14. Company Profiles
14.1. Piramal Pharma Solutions*
14.1.1. Company Overview
14.1.2. Product Portfolio and Description
14.1.3. Financial Overview
14.1.4. Key Developments
14.2. Biopta
14.3. Charles River Laboratories International
14.4. Domainex
14.5. Evotec AG
14.6. Albany Molecular Research Inc.
14.7. GenScript
14.8. Pharmaceutical Product Development, LLC (PPD)
14.9. WuXi AppTec
14.10. Merck & Co., Inc.
LIST NOT EXHAUSTIVE
15. Appendix
15.1. About Us and Services
15.2. Contact Us